{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T11:47:00Z","timestamp":1782906420789,"version":"3.54.5"},"reference-count":38,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T00:00:00Z","timestamp":1027555200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2002,8]]},"abstract":"<jats:p><jats:bold>Summary.<\/jats:bold> The impact of various types of intensification therapy was examined in a cohort of 3617 children aged 1\u201314\u2003years with acute lymphoblastic leukaemia (ALL) enrolled in the Medical Research Council (MRC) UKALL X (1985\u201390) and UKALL XI (1990\u201397) trials. UKALL XI was modified in 1992 to incorporate the \u2018best arm\u2019 of UKALL X with two 5\u2010d intensification blocks at 5 and 20\u2003weeks, and an additional randomization in respect of a third intensification at 35\u2003weeks but omission of two consecutive injections of daunorubicin during induction. All children were eligible for randomization irrespective of risk group. The impact of the various types of intensification therapy was examined in a stratified analysis. At a median follow up of 102\u2003months, both trials had an identical event\u2010free survival of 61% (95% CI 58\u201363%) at 8\u2003years. Survival at 8\u2003years in UKALL XI was significantly better in than in UKALL X, 81% (79\u201383%) compared with 74% (72\u201376%) (<jats:italic>P<\/jats:italic>\u2003=\u2003&lt;\u20030\u00b7001), owing to improved management of relapse. There was a highly significant trend in reduction of the number of relapses and deaths with increased intensity of therapy both for children with initial leucocyte count &lt;\u200a50\u2003\u00d7\u200310<jats:sup>9<\/jats:sup>\/l (<jats:italic>P<\/jats:italic>\u2003=\u2003&lt;\u20030\u00b7001) and \u2265\u200a50\u2003\u00d7\u200310<jats:sup>9<\/jats:sup>\/l (<jats:italic>P<\/jats:italic>\u2003=\u20030\u00b7002). Introduction of a third late intensification block compensated for omission of anthracyclines during induction but produced little additional benefit. These results show, in a large cohort of patients, that minor modifications of therapy may influence relapse rate and obviate the benefit of previous randomized trials. The failure to adapt treatment for higher risk children contributed to these disappointing results<jats:italic>.<\/jats:italic><\/jats:p>","DOI":"10.1046\/j.1365-2141.2002.03647.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:46:33Z","timestamp":1047365193000},"page":"445-455","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Failure of a new protocol to improve treatment results in paediatric lymphoblastic leukaemia: lessons from the UK Medical Research Council trials UKALL X and UKALL XI"],"prefix":"10.1111","volume":"118","author":[{"given":"Judith M.","family":"Chessells","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgina","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda E.","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifford C.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank G. H.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian M.","family":"Hann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Medical","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Research Council Working Party","family":"On Childhood Leukaemia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2002,7,25]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1991.9.6.1012"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/0959-8049(96)00131-1"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/0277-5379(91)90269-J"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.01849.x"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)90164-7"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1995.tb03313.x"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.3493163.x"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)91615-3"},{"key":"e_1_2_6_10_1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1200\/JCO.1995.13.2.339","article-title":"Levels of 1\u2010asparagine in CSF after intramuscular administration of asparaginase from Erwinia in children with acute lymphoblastic leukaemia","volume":"13","author":"Dibenedetto S.P.","year":"1995","journal-title":"Journal of Clinical Oncology"},{"key":"e_1_2_6_11_1","first-page":"125","article-title":"Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and l\u2010asparaginase for standard risk childhood acute lymphocytic leukemia: results of a Dutch phase III study (ALL V)","volume":"11","author":"Van Der Does\u2010van den Berg A.","year":"1989","journal-title":"American Journal of Pediatric Hematology\/Oncology"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.2950180612"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1991.tb04415.x"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401962"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-911X(199702)28:2<98::AID-MPO3>3.3.CO;2-G"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1993.11.11.2234"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401939"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401093"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401704"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.02668.x"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.02543.x"},{"key":"e_1_2_6_22_1","first-page":"466a","article-title":"UKALL XI randomized trial stratified CNS treatments and prospective neurophychological assessment in childhood acute lymphoblastic leukaemia (ALL)","volume":"96","author":"Hill F.G.H.","year":"2000","journal-title":"Blood"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-911X(199607)27:1<15::AID-MPO4>3.0.CO;2-X"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.01891.x"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.1002914.x"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.2950140317"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199806043382304"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1977.1"},{"key":"e_1_2_6_29_1","first-page":"150","article-title":"Impact of three methods of treatment intensification on acute lymphoblastic leukemia in children: Long\u2010term results of St Jude Total Therapy Study X","volume":"6","author":"Pui C.\u2010H.","year":"1992","journal-title":"Leukemia"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401065"},{"key":"e_1_2_6_31_1","first-page":"299","article-title":"The Berlin Childhood Acute Lymphoblastic Leukemia Therapy Study, 1970\u201376","volume":"2","author":"Riehm H.","year":"1980","journal-title":"American Journal of Pediatric Hematology\/Oncology"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.5.1297"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401973"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401977"},{"key":"e_1_2_6_35_1","first-page":"3310","article-title":"Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL\u2010BFM 90. German\u2010Austrian\u2010Swiss ALL\u2010BFM Study Group","volume":"95","author":"Schrappe M.","year":"2000","journal-title":"Blood"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.5.1211"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.1.61"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1993.11.3.527"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.7.2412.h8002412_2412_2418"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2002.03647.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2002.03647.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2002.03647.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T02:10:50Z","timestamp":1697422250000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2002.03647.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7,25]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,8]]}},"alternative-id":["10.1046\/j.1365-2141.2002.03647.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2002.03647.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,7,25]]},"assertion":[{"value":"2002-07-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}